Pharmaceutical Analysis & Statistics in Oceania Countries, April 2012 (p8)

Australian Pharmaceutical Industries Limited: Retailing Company Profile, SWOT & Financial Report

$ 125
Company report
April 2012
by Canadean Ltd

Synopsis Canadean's "Australian Pharmaceutical Industries Limited: Retailing Company Profile, SWOT & Financial Report" contains in depth information and data about the company and its operations. The profile ...

Industries : Pharmacies and Drug Stores
Countries : Australia

Disease and Therapy Review: Gastroesophageal Reflux Disease (GERD)

$ 995
Industry report
April 2012
by Timely Data Resources Inc.

The Gastroesophageal Reflux Disease (GERD) Disease and Therapy Review provides an overview of the disease and related conditions, with prevalence numbers and percentages for major countries worldwide, ...

Industries : Therapy
Countries : World, Australia, Argentina, Brazil, Sweden, Italy, Germany, Taiwan, Japan, China, Europe, United States, South America, Asia

MarketVIEW: Staphylococcus aureus vaccines

$ 9 995
Industry report
April 2012
by VacZine Analytics Group Of Assay Advantage Ltd

Gram-positive Staphylococcus aureus is an opportunistic pathogen and a major cause of patient morbidity and mortality, especially in "at risk" populations. The organism can cause a wide range of infections ...

Industries : Drug and Medication
Countries : United States, France, Germany, Europe, Australia, Canada, United Kingdom, Spain, Italy, Japan, World

OTC Pharmaceuticals Market Overview in Australia

$ 350
Industry report
March 2012
by MarketLine

It includes data on industry size and key market segments, plus textual and graphical analysis of the major trends and drivers and key competitors, main industry players and demographic information. What's ...

Industries : Over-the-counter Drug
Countries : Australia

Avastra Sleep Centres Limited (Symbol:AVS) SWOT Analysis, Strategy, Revenues and Profits

$ 250
Company report
March 2012
by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

Industries : Drug Discovery and Development
Countries : United States, Australia

Halcygen Pharmaceuticals Limited (MYX) - Financial and Strategic SWOT Analysis Review

$ 250
Company report
March 2012
by Global Data

Halcygen Pharmaceuticals Limited (Halcygen) is focused on the improvement and reformulation of existing drugs. The company has two products under development which include SUBA-itraconazole and Minocycline. ...

Industries : Drug and Medication
Countries : Australia

Sigma Pharmaceuticals Limited - Strategy and SWOT Report

$ 175
Company report
March 2012
by MarketLine

Sigma Pharmaceuticals Limited - Strategy and SWOT Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service ...

Industries : Pharmaceutical
Countries : Australia, New Zealand

World Drug Discovery and Development: Chronic Idiopathic Myelofibrosis - Pipeline Review, H1 2012

$ 500
Company report
March 2012
by Global Markets Direct

This report provides data on the therapeutic development for Chronic Idiopathic Myelofibrosis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews ...

Industries : Drug Discovery and Development
Countries : World, Australia

Vaccines - Australia

$ 652
Industry report
March 2012
by Global Research & Data Services

This market research report offers an in-depth perspective on the actual market situation, trends and future outlook for vaccines in Australia. The analysis provides essential market information for decision-makers ...

Industries : Drug and Medication
Countries : Australia

Analgesics Market Analysis in New Zealand

$ 898
Industry report
March 2012
by Euromonitor International

Acetaminophen accounted for 39% of analgesics current retail value sales in 2011. In addition to falling sales within acetaminophen, aspirin has also reached a very high level of maturity. Euromonito ...

Industries : Drug and Medication
Countries : New Zealand

Digestive Remedies Market Analysis in New Zealand

$ 898
Industry report
March 2012
by Euromonitor International

Towards the latter end of the review period, consumers were extremely price conscious and this trend continued within digestive remedies during 2011. Euromonitor International's report offers a comprehensive ...

Industries : Drug and Medication
Countries : New Zealand

Cough, Cold and Allergy (Hay Fever) Remedies Market Analysis in New Zealand

$ 898
Industry report
March 2012
by Euromonitor International

This followed an agreement by the cabinet in September 2009 to reclassify these two drugs considering the fact they are active ingredients used in the manufacture of the Class A controlled drug methamphetamine. ...

Industries : Drug and Medication
Countries : New Zealand

Vitamins and Dietary Supplements Market Analysis in New Zealand

$ 898
Industry report
March 2012
by Euromonitor International

br> Euromonitor International's report offers a comprehensive guide to the size and shape of the industry at a national level. It provides the latest retail sales data from 2007 to 2011, allowing you to ...

Industries : Vitamin and Supplement
Countries : New Zealand

Engaging KOLs: new thinking on thought leader development

$ 595
Industry report
March 2012
by Firstword Pharma

Key opinion leaders (KOLs) play a vital role in the effective development and marketing of drugs and medical devices. However, restrictions are increasingly being imposed on the ways in which Medical ...

Industries : Drug Discovery and Development
Countries : United States, Australia

Sigma Pharmaceuticals Limited - SWOT Analysis

$ 175
Company report
March 2012
by MarketLine

Sigma Pharmaceuticals Limited - SWOT Analysis company profile is the essential source for top-level company data and information. Sigma Pharmaceuticals Limited - SWOT Analysis examines the company's key ...

Industries : Pharmaceutical
Countries : Australia, New Zealand, Oceania

Biotron Limited (BIT) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

$ 250
Company report
March 2012
by Global Data

Biotron Limited (BIT) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Summary Biotron Limited is an Australian biotechnology company, incepted in 1999. The company is engaged in developing ...

Industries : Drug Discovery and Development
Countries : Australia

NeuroDiscovery Ltd (NDL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

$ 250
Company report
March 2012
by Global Data

NeuroDiscovery Ltd (NDL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Summary NeuroDiscovery Ltd (NeuroDiscovery) is an Australian-based neuroscience drug development company. It engages ...

Industries : Drug Discovery and Development
Countries : Australia

Pharmaceuticals Market Overview in Australia -

$ 599
Industry report
February 2012
by Mintel

Pharmaceuticals in Australia by Mintel Global Industry Navigator provides you with annual year-end industry size figures, most recently updated in 2011. This industry includes prescription and OTC pharmaceuticals. ...

Industries : Pharmaceutical
Countries : Australia

Pathology in Australia: Bronchitis - Pipeline Review, H1 2012

$ 500
Company report
February 2012
by Global Markets Direct

This report provides data on the therapeutic development for Bronchitis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved ...

Industries : Pathology
Countries : Australia, World, United States

Pharmaceuticals Market Overview in Australia Market Overview in

$ 599
Industry report
February 2012
by Mintel

Pharmaceuticals in Australia by Mintel Global Industry Navigator provides you with annual year-end industry size figures, most recently updated in 2011. This industry includes prescription and OTC pharmaceuticals. ...

Industries : Pharmaceutical
Countries : Australia

Biogen Idec Inc.: Pharmaceuticals and Healthcare Company profile, SWOT & Financial Report

$ 125
Company report
February 2012
by ICD Research

Synopsis ICD Research's "Biogen Idec Inc.: Pharmaceuticals and Healthcare Company profile, SWOT & Financial Report" contains in depth information and data about the company and its operations. The profile ...

Industries : Pathology
Countries : United States, Australia, Canada, Japan, World

Emergency Contraception Market Overview in Australia

$ 898
Industry report
February 2012
by Euromonitor International

In 2009, emergency contraception grew by 9% in current value terms to reach value sales of A$730,000 in Australia. Schering Pty Ltd reached out to educate member pharmacies in the Pharmacy Self Care's ...

Industries : Drug and Medication
Countries : Australia

Calming and Sleeping Market Overview in Australia

$ 898
Industry report
February 2012
by Euromonitor International

Calming and sleeping products grew by 6% in current value during 2009, with sales reaching A$12 million. OTC calming and sleeping products, particularly herbal/traditional remedies, are still benefiting ...

Industries : Drug and Medication
Countries : Australia

Ear Care Market Overview in Australia

$ 898
Industry report
February 2012
by Euromonitor International

Sales in ear care increased by 4% in current value terms in 2009 to reach A$11 million in Australia. Similar to the preceding year, there was little product innovation in in ear care and manufacturers ...

Industries : Drug and Medication
Countries : Australia

Analgesics Market Overview in Australia

$ 898
Industry report
February 2012
by Euromonitor International

Following on the concerns about codeine-based analgesics misuse and consequent medical conditions including stomach ulcers and renal failure, the TGA decided on the upscheduling of combination products ...

Industries : Drug and Medication
Countries : Australia

Adult Mouth Care Market Overview in Australia

$ 898
Industry report
February 2012
by Euromonitor International

Adult mouth care attained a current value growth of 8% during 2009, reaching sales of A$35 million in 2009. The state of oral health in Australia has attracted the attention of health agencies, after it ...

Industries : Drug and Medication
Countries : Australia

NRT Smoking Cessation Aids Market Analysis in Australia

$ 898
Industry report
February 2012
by Euromonitor International

The first of these was the growing availability of these products through supermarkets. Until 2011 Nicabate was the only NRT smoking cessation aid product available in supermarkets, but 2011 saw Nicorette ...

Industries : Drug and Medication
Countries : Australia

Cough, Cold and Allergy (Hay Fever) Remedies Market Analysis in Australia

$ 898
Industry report
February 2012
by Euromonitor International

The end of the review period saw a particularly damp spring, for example, producing a particularly strong hay fever season, while cases of cold and flu also leapt considerably, particularly in Canberra ...

Industries : Drug and Medication
Countries : Australia

Digestive Remedies Market Analysis in Australia

$ 898
Industry report
February 2012
by Euromonitor International

There are several reasons for such strong growth, but Australia's ageing population has the greatest influence. As consumers grow older they become more prone to such conditions as constipation as well ...

Industries : Drug and Medication
Countries : Australia

Vitamins and Dietary Supplements Market Analysis in Australia

$ 898
Industry report
February 2012
by Euromonitor International

billion. Health and wellness trends in Australian society have encouraged consumers to take greater care of their health, and maintain optimal nutritional condition. Vitamins and dietary supplements also ...

Industries : Vitamin and Supplement
Countries : Australia